Professional Documents
Culture Documents
17 FEB FEB2014: Weekly Stock Weekly Stock Analysis
17 FEB FEB2014: Weekly Stock Weekly Stock Analysis
17 FEB FEB2014: Weekly Stock Weekly Stock Analysis
MARKET WRAP
The broader Nifty closed up 47.25 gains 0.79%, while the benchmark BSE close up 173.47 gains 0.86%. Indian Equity Market extended its northward journey in last hour of trade supported by technology, private banks and oil & gas stocks. Tata Motors topped the buying list, rising 3% on value buying after strong Jan. sales numbers reported by JLR. SBI disappointed with the net profit falling 34.2% YoY to Rs 2234.34 cr. in the quarter ended.
4 callls hit targets we had given last week, in which AURO PHARMA hit 1st target & made low464.80(sell call given@473), KTK hit 1ST target & made low92.50(sell call given@96.60), VOLTAS hit all target & made high125.40(buy call given@107),CROMPGREAVE hit all target & made high127.15(buy call given@115.50).
PRICE
94.50
STOCK RECOMMENDATION
BUY BUY SELL SELL SELL
189.65
492.55 119.40 122.35
KTK BANK
S2 85
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING BUY SIGNAL IN KTK BANK SO TRADER CAN BUY KTK BANK AT 94.50 FOR TG-97/101
SSLT
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING BUY SIGNAL IN SSLT SO TRADER CAN BUY SSLT AT 189.65 FOR TG-194/200
AURO PHARMA
S2 470
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING SELL SIGNAL IN AURO PHARMA FUTURES SO TRADER CAN SELL AURO PHARMA AT 492.55 FOR TG-485/475
VOLTAS
S2 110
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING SELL SIGNAL IN VOLTAS SO TRADER CAN SELL VOLTAS AT 119.40 FOR TG-117/113.50
CROMPGREAVES
S1 115
S2 110
TECHNICAL OVERVIEW
STOCHASTIC OSCILLATORS INDICATING SELL SIGNAL IN CROMPGREAVES SO TRADER CAN SELL CROMPGREAVES AT 122.35 FOR TG-120/116
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein CAN be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. TheEquicom recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. TheEquicom shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to TheEquicom might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in Commodity and equity market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above. TheEquicom does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.